TrialJournal of the European Academy of Dermatology and Venereology : JEADV2017

Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis.

A Blauvelt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.